12 November 2024
Barclays PLC
Transaction in own shares
Barclays PLC (the "Company") announces that it has purchased for cancellation the following number of its ordinary shares of
Date of purchase: |
11 November 2024 |
Number of ordinary shares purchased: |
5,109,791 |
Highest price paid per share: |
261.5500p |
Lowest price paid per share: |
254.2500p |
Volume weighted average price paid per share: |
258.3276p
|
The Company intends to cancel all of the purchased ordinary shares.
Following the cancellation of the repurchased shares, the Company's issued share capital will consist of 14,470,057,805 ordinary shares with voting rights.
There are no ordinary shares held in Treasury.
The above figure (14,470,057,805) may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.
In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018, as amended, a full breakdown of the individual purchases of ordinary shares made by Citigroup Global Markets Limited on behalf of the Company can be found at:
http://www.rns-pdf.londonstockexchange.com/rns/7874L_1-2024-11-11.pdf
Since the commencement of the share buy-back programme announced on 5 August 2024, the Company has purchased 266,073,786 ordinary shares on the London Stock Exchange in aggregate at a volume weighted average price of 228.7158p per ordinary share.
- ENDS -
For further information, please contact:
Investor Relations |
Media Relations |
Marina Shchukina +44 (0) 20 7116 2526 |
Tom Hoskin +44 (0) 20 7116 4755 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.